{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:20:39Z","timestamp":1780392039013,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03381-y","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T21:25:49Z","timestamp":1773782749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Polymer-stabilized Liquid\u2013liquid Phase Separation on the Permeability Across the Corneal Barrier"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8244-2960","authenticated-orcid":false,"given":"C. C.","family":"Sruthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0789-3713","authenticated-orcid":false,"given":"Gayathri","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5626-5020","authenticated-orcid":false,"given":"Indhu Annie","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9333-9163","authenticated-orcid":false,"given":"M.","family":"Sabitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Sudheesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"3381_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejpb.2018.09.014","volume":"132","author":"K Kawakami","year":"2018","unstructured":"Kawakami K, Sato K, Fukushima M, Miyazaki A, Yamamura Y, Sakuma S. Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption. Eur J Pharm Biopharm. 2018;132:146\u201356.","journal-title":"Eur J Pharm Biopharm."},{"key":"3381_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1021\/MP500573Z","volume":"12","author":"LI Mosquera-Giraldo","year":"2015","unstructured":"Mosquera-Giraldo LI, Taylor LS. Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir. Mol Pharm. 2015;12:496\u2013503. https:\/\/doi.org\/10.1021\/MP500573Z.","journal-title":"Mol Pharm."},{"key":"3381_CR3","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1021\/acs.molpharmaceut.5b00056","volume":"12","author":"AS Indulkar","year":"2015","unstructured":"Indulkar AS, Box KJ, Taylor R, Ruiz R, Taylor LS. pH-dependent liquid-liquid phase separation of highly supersaturated solutions of weakly basic drugs. Mol Pharm. 2015;12:2365\u201377. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00056.","journal-title":"Mol Pharm."},{"key":"3381_CR4","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1021\/acs.molpharmaceut.6b00202","volume":"13","author":"AS Indulkar","year":"2016","unstructured":"Indulkar AS, Gao Y, Raina SA, Zhang GGZ, Taylor LS. Exploiting the phenomenon of liquid-liquid phase separation for enhanced and sustained membrane transport of a poorly water-soluble drug. Mol Pharm. 2016;13:2059\u201369.","journal-title":"Mol Pharm."},{"key":"3381_CR5","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1007\/s11095-015-1712-4","volume":"32","author":"SA Raina","year":"2015","unstructured":"Raina SA, Zhang GGZ, Alonzo DE, Wu J, Zhu D, Catron ND, et al. Impact of solubilizing additives on supersaturation and membrane transport of drugs. Pharm Res. 2015;32:3350\u201364. https:\/\/doi.org\/10.1007\/s11095-015-1712-4.","journal-title":"Pharm Res."},{"key":"3381_CR6","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1021\/acs.molpharmaceut.7b00338","volume":"14","author":"AM Stewart","year":"2017","unstructured":"Stewart AM, Grass ME, Brodeur TJ, Goodwin AK, Morgen MM, Friesen DT, et al. Impact of drug-rich colloids of itraconazole and HPMCAS on membrane flux in vitro and oral bioavailability in rats. Mol Pharm. 2017;14:2437\u201349. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00338.","journal-title":"Mol Pharm."},{"key":"3381_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.xphs.2021.07.003","volume":"111","author":"SS Hate","year":"2022","unstructured":"Hate SS, Mosquera-Giraldo LI, Taylor LS. A mechanistic study of drug mass transport from supersaturated solutions across PAMPA membranes. J Pharm Sci. 2022;111:102\u201315. https:\/\/doi.org\/10.1016\/j.xphs.2021.07.003.","journal-title":"J Pharm Sci."},{"key":"3381_CR8","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1021\/acs.molpharmaceut.3c01078","volume":"21","author":"E Yoshikawa","year":"2024","unstructured":"Yoshikawa E, Ueda K, Hakata R, Higashi K, Moribe K. Quantitative investigation of intestinal drug absorption enhancement by drug-rich nanodroplets generated via liquid-liquid phase separation. Mol Pharm. 2024;21:1745\u201355. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c01078.","journal-title":"Mol Pharm."},{"key":"3381_CR9","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1021\/acs.molpharmaceut.2c00565","volume":"19","author":"R Sabra","year":"2022","unstructured":"Sabra R, Narula A, Taylor LS, Li N. Comparisons of in vitro models to evaluate the membrane permeability of amorphous drug nanoparticles. Mol Pharm. 2022;19:3412\u201328. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00565.","journal-title":"Mol Pharm."},{"key":"3381_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejpb.2019.12.002","volume":"146","author":"M Imono","year":"2020","unstructured":"Imono M, Uchiyama H, Yoshida S, Miyazaki S, Tamura N, Tsutsumimoto H, et al. The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro-in vivo correlation of nanocrystals. Eur J Pharm Biopharm. 2020;146:84\u201392. https:\/\/doi.org\/10.1016\/j.ejpb.2019.12.002.","journal-title":"Eur J Pharm Biopharm."},{"key":"3381_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1021\/acs.molpharmaceut.5b00710","volume":"13","author":"S Kimura","year":"2016","unstructured":"Kimura S, Kasatani S, Tanaka M, Araki K, Enomura M, Moriyama K, et al. Importance of the direct contact of amorphous solid particles with the surface of monolayers for the transepithelial permeation of curcumin. Mol Pharm. 2016;13:493\u20139. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00710.","journal-title":"Mol Pharm."},{"key":"3381_CR12","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/jps.23979","volume":"103","author":"KJ Frank","year":"2014","unstructured":"Frank KJ, Westedt U, Rosenblatt KM, H\u00f6lig P, Rosenberg J, M\u00e4gerlein M, et al. What is the mechanism behind increased permeation rate of a poorly soluble drug from aqueous dispersions of an amorphous solid dispersion? J Pharm Sci. 2014;103:1779\u201386. https:\/\/doi.org\/10.1002\/jps.23979.","journal-title":"J Pharm Sci."},{"key":"3381_CR13","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1021\/acs.molpharmaceut.7b00294","volume":"14","author":"C Roos","year":"2017","unstructured":"Roos C, Dahlgren D, Berg S, Westergren J, Abrahamsson B, Tannergren C, et al. In vivo mechanisms of intestinal drug absorption from aprepitant nanoformulations. Mol Pharm. 2017;14:4233\u201342. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00294.","journal-title":"Mol Pharm."},{"key":"3381_CR14","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.xphs.2019.04.006","volume":"108","author":"F Kesisoglou","year":"2019","unstructured":"Kesisoglou F, Wang M, Galipeau K, Harmon P, Okoh G, Xu W. Effect of amorphous nanoparticle size on bioavailability of anacetrapib in dogs. J Pharm Sci. 2019;108:2917\u201325. https:\/\/doi.org\/10.1016\/j.xphs.2019.04.006.","journal-title":"J Pharm Sci."},{"key":"3381_CR15","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1021\/acs.molpharmaceut.0c00061","volume":"17","author":"K Ueda","year":"2020","unstructured":"Ueda K, Taylor LS. Polymer type impacts amorphous solubility and drug-rich phase colloidal stability: A mechanistic study using nuclear magnetic resonance spectroscopy. Mol Pharm. 2020;17:1352\u201362.","journal-title":"Mol Pharm."},{"key":"3381_CR16","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1021\/acs.molpharmaceut.7b00178","volume":"14","author":"K Ueda","year":"2017","unstructured":"Ueda K, Higashi K, Moribe K. Direct NMR monitoring of phase separation behavior of highly supersaturated nifedipine solution stabilized with hypromellose derivatives. Mol Pharm. 2017;14:2314\u201322. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00178.","journal-title":"Mol Pharm"},{"key":"3381_CR17","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1021\/acs.molpharmaceut.1c00055","volume":"18","author":"R Yang","year":"2021","unstructured":"Yang R, Mann AKP, Van Duong T, Ormes JD, Okoh GA, Hermans A, et al. Drug release and nanodroplet formation from amorphous solid dispersions: Insight into the roles of drug physicochemical properties and polymer selection. Mol Pharm. 2021;18:2066\u201381.","journal-title":"Mol Pharm."},{"key":"3381_CR18","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1021\/acs.molpharmaceut.8b00104","volume":"15","author":"LI Mosquera-Giraldo","year":"2018","unstructured":"Mosquera-Giraldo LI, Li N, Wilson VR, Nichols BLB, Edgar KJ, Taylor LS. Influence of polymer and drug loading on the release profile and membrane transport of telaprevir. Mol Pharm. 2018;15:1700\u201313. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00104.","journal-title":"Mol Pharm."},{"key":"3381_CR19","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1021\/acs.molpharmaceut.0c00833","volume":"18","author":"VR Wilson","year":"2021","unstructured":"Wilson VR, Mugheirbi NA, Mosquera-Giraldo LI, Deac A, Moseson DE, Smith DT, et al. Interaction of polymers with enzalutamide nanodroplets-impact on droplet properties and induction times. Mol Pharm. 2021;18:836\u201349. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00833.","journal-title":"Mol Pharm."},{"key":"3381_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jconrel.2020.12.018","volume":"330","author":"K Ueda","year":"2021","unstructured":"Ueda K, Taylor LS. Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size. J Control Release. 2021;330:229\u201343. https:\/\/doi.org\/10.1016\/j.jconrel.2020.12.018.","journal-title":"J Control Release."},{"key":"3381_CR21","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1021\/acs.molpharmaceut.5b00863","volume":"13","author":"P Harmon","year":"2016","unstructured":"Harmon P, Galipeau K, Xu W, Brown C, Wuelfing WP. Mechanism of dissolution-induced nanoparticle formation from a copovidone-based amorphous solid dispersion. Mol Pharm. 2016;13:1467\u201381. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00863.","journal-title":"Mol Pharm."},{"key":"3381_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125541","volume":"675","author":"G Ramachandran","year":"2025","unstructured":"Ramachandran G, Chacko IA, Mishara MG, Khopade AJ, Sabitha M, Sudheesh MS. A review on design rules for formulating amorphous solid dispersions based on drug-polymer interactions in aqueous environment. Int J Pharm. 2025;675:125541. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125541.","journal-title":"Int J Pharm."},{"key":"3381_CR23","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1021\/mp400228x","volume":"10","author":"GA Ilevbare","year":"2013","unstructured":"Ilevbare GA, Liu H, Pereira J, Edgar KJ, Taylor LS. Influence of additives on the properties of nanodroplets formed in highly supersaturated aqueous solutions of ritonavir. Mol Pharm. 2013;10:3392\u2013403. https:\/\/doi.org\/10.1021\/mp400228x.","journal-title":"Mol Pharm."},{"key":"3381_CR24","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1021\/cg301679h","volume":"13","author":"GA Ilevbare","year":"2013","unstructured":"Ilevbare GA, Taylor LS. Liquid-liquid phase separation in highly supersaturated aqueous solutions of poorly water-soluble drugs: Implications for solubility enhancing formulations. Cryl Growth Design. 2013;13:1497\u2013509. https:\/\/doi.org\/10.1021\/cg301679h.","journal-title":"Cryl Growth Design."},{"key":"3381_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/PHARMACEUTICS13020220","volume":"13","author":"K Suzuki","year":"2021","unstructured":"Suzuki K, Kawakami K, Fukiage M, Oikawa M, Nishida Y, Matsuda M, et al. Relevance of liquid-liquid phase separation of supersaturated solution in oral absorption of albendazole from amorphous solid dispersions. Pharmaceutics. 2021;13:220. https:\/\/doi.org\/10.3390\/PHARMACEUTICS13020220.","journal-title":"Pharmaceutics"},{"key":"3381_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejpb.2020.04.017","volume":"152","author":"J Plum","year":"2020","unstructured":"Plum J, Bavnh\u00f8j CG, Eliasen JN, Rades T, M\u00fcllertz A. Comparison of induction methods for supersaturation: Amorphous dissolution versus solvent shift. Eur J Pharm Biopharm. 2020;152:35\u201343.","journal-title":"Eur J Pharm Biopharm."},{"key":"3381_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejps.2017.02.042","volume":"102","author":"Y Tsume","year":"2017","unstructured":"Tsume Y, Matsui K, Searls AL, Takeuchi S, Amidon GE, Sun D, et al. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS). Eur J Pharm Sci. 2017;102:126\u201339. https:\/\/doi.org\/10.1016\/j.ejps.2017.02.042.","journal-title":"Eur J Pharm Sci."},{"key":"3381_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1208\/s12249-019-1555-0","volume":"21","author":"H Bhalerao","year":"2020","unstructured":"Bhalerao H, Koteshwara KB, Chandran S. Brinzolamide dimethyl sulfoxide in situ gelling ophthalmic solution: formulation optimisation and in vitro and in vivo evaluation. AAPS PharmSciTech. 2020;21:69. https:\/\/doi.org\/10.1208\/s12249-019-1555-0.","journal-title":"AAPS PharmSciTech."},{"key":"3381_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/15569527.2019.1579225","volume":"38","author":"JS Pelletier","year":"2019","unstructured":"Pelletier JS, Devine J, Capriotti K, Barone SB, Capriotti JA. Topical application of povidone-iodine\/dimethylsulfoxide ophthalmic gel preparation in Dutch-Belted rabbits. Cutan Ocul Toxicol. 2019;38:221\u20136. https:\/\/doi.org\/10.1080\/15569527.2019.1579225.","journal-title":"Cutan Ocul Toxicol."},{"key":"3381_CR30","doi-asserted-by":"crossref","unstructured":"Yang M, Gong W, Wang Y, Shan L, Li Y, Gao C. Bioavailability improvement strategies for poorly water-soluble drugs based on the supersaturation mechanism: An update. J Pharm Pharm Sci. 2016;19:208\u201325. 10.18433\/J3W904","DOI":"10.18433\/J3W904"},{"key":"3381_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1021\/acs.molpharmaceut.9b00889","volume":"17","author":"AM Stewart","year":"2020","unstructured":"Stewart AM, Grass ME. Practical approach to modeling the impact of amorphous drug nanoparticles on the oral absorption of poorly soluble drugs. Mol Pharm. 2020;17:180\u20139.","journal-title":"Mol Pharm."},{"key":"3381_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/J.IJPHARM.2013.05.013","volume":"453","author":"S Xua","year":"2013","unstructured":"Xua S, Dai WG. Drug precipitation inhibitors in supersaturable formulations. Int J Pharm. 2013;453:36\u201343. https:\/\/doi.org\/10.1016\/J.IJPHARM.2013.05.013.","journal-title":"Int J Pharm."},{"key":"3381_CR33","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1007\/s11095-015-1725-z","volume":"32","author":"SA Raina","year":"2015","unstructured":"Raina SA, Alonzo DE, Zhang GGZ, Gao Y, Taylor LS. Using environment-sensitive fluorescent probes to characterize liquid-liquid phase separation in supersaturated solutions of poorly water soluble compounds. Pharm Res. 2015;32:3660\u201373. https:\/\/doi.org\/10.1007\/s11095-015-1725-z.","journal-title":"Pharm Res."},{"key":"3381_CR34","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1021\/acs.molpharmaceut.2c00124","volume":"19","author":"A Narula","year":"2022","unstructured":"Narula A, Sabra R, Li N. Mechanisms and extent of enhanced passive permeation by colloidal drug particles. Mol Pharm. 2022;19:3085\u201399. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00124.","journal-title":"Mol Pharm."},{"key":"3381_CR35","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1021\/acs.molpharmaceut.7b00740","volume":"14","author":"SS Hate","year":"2017","unstructured":"Hate SS, Reutzel-Edens SM, Taylor LS. Absorptive dissolution testing of supersaturating systems: impact of absorptive sink conditions on solution phase behavior and mass transport. Mol Pharm. 2017;14:4052\u201363. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00740.","journal-title":"Mol Pharm."},{"key":"3381_CR36","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s11095-013-1216-z","volume":"31","author":"B Van Eerdenbrugh","year":"2014","unstructured":"Van Eerdenbrugh B, Raina S, Hsieh Y-L, Augustijns P, Taylor LS. Classification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments. Pharm Res. 2014;31:969\u201382. https:\/\/doi.org\/10.1007\/s11095-013-1216-z.","journal-title":"Pharm Res."},{"key":"3381_CR37","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/pharmaceutics15061646","volume":"15","author":"CP Santana","year":"2023","unstructured":"Santana CP, Matter BA, Patil MA, Silva-Cunha A, Kompella UB. Corneal permeability and uptake of twenty-five drugs: species comparison and quantitative structure\u2013permeability relationships. Pharmaceutics. 2023;15:1646. https:\/\/doi.org\/10.3390\/pharmaceutics15061646.","journal-title":"Pharmaceutics."},{"key":"3381_CR38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejps.2018.04.016","volume":"119","author":"P Berben","year":"2018","unstructured":"Berben P, Bauer-Brandl A, Brandl M, Faller B, Flaten GE, Jacobsen A-C, et al. Drug permeability profiling using cell-free permeation tools: Overview and applications. Eur J Pharm Sci. 2018;119:219\u201333. https:\/\/doi.org\/10.1016\/j.ejps.2018.04.016.","journal-title":"Eur J Pharm Sci."},{"key":"3381_CR39","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12565-020-00590-8","volume":"96","author":"SK Subasinghe","year":"2021","unstructured":"Subasinghe SK, Ogbuehi KC, Mitchell L, Dias GJ. Animal model with structural similarity to human corneal collagen fibrillar arrangement. Anat Sci Int. 2021;96:286\u201393. https:\/\/doi.org\/10.1007\/s12565-020-00590-8.","journal-title":"Anat Sci Int."},{"key":"3381_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121105","volume":"608","author":"FA Maulvi","year":"2021","unstructured":"Maulvi FA, Shetty KH, Desai DT, Shah DO, Willcox MDP. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration. Int J Pharm. 2021;608:121105. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.121105.","journal-title":"Int J Pharm."},{"key":"3381_CR41","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","volume":"24","author":"A Subrizi","year":"2019","unstructured":"Subrizi A, Del Amo EM, Korzhikov-Vlakh V, Tennikova T, Ruponen M, Urtti A. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties. Drug Discov Today. 2019;24:1446\u201357. https:\/\/doi.org\/10.1016\/j.drudis.2019.02.001.","journal-title":"Drug Discov Today."},{"key":"3381_CR42","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.ajo.2011.05.015","volume":"152","author":"AL Hennessy","year":"2011","unstructured":"Hennessy AL, Katz J, Covert D, Kelly CA, Suan EP, Speicher MA, et al. A video study of drop instillation in both glaucoma and retina patients with visual impairment. Am J Ophthalmol. 2011;152:982\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2011.05.015.","journal-title":"Am J Ophthalmol."},{"key":"3381_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular drug delivery: A comprehensive review. AAPS PharmSciTech. 2023;24:66. https:\/\/doi.org\/10.1208\/s12249-023-02516-9.","journal-title":"AAPS PharmSciTech."},{"key":"3381_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03639045.2021.1879843","volume":"47","author":"P Ashwathy","year":"2021","unstructured":"Ashwathy P, Anto AT, Sudheesh MS. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions. Drug Dev Ind Pharm. 2021;47:1\u201311. https:\/\/doi.org\/10.1080\/03639045.2021.1879843.","journal-title":"Drug Dev Ind Pharm."},{"key":"3381_CR45","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1002\/jps.23093","volume":"101","author":"SH Yalkowsky","year":"2012","unstructured":"Yalkowsky SH. Perspective on improving passive human intestinal absorption. J Pharm Sci. 2012;101:3047\u201350. https:\/\/doi.org\/10.1002\/jps.23093.","journal-title":"J Pharm Sci."},{"key":"3381_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1208\/s12249-021-02125-4","volume":"22","author":"G Ramachandran","year":"2021","unstructured":"Ramachandran G, Sudheesh MS. Role of permeability on the biopredictive dissolution of amorphous solid dispersions. AAPS PharmSciTech. 2021;22:243. https:\/\/doi.org\/10.1208\/s12249-021-02125-4.","journal-title":"AAPS PharmSciTech."},{"key":"3381_CR47","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1023\/a:1018890422825","volume":"16","author":"FP Schwarb","year":"1999","unstructured":"Schwarb FP, Imanidis G, Smith EW, Haigh JM, Surber C. Effect of concentration and degree of saturation of topical fluocinonide formulations on in vitro membrane transport and in vivo availability on human skin. Pharm Res. 1999;16:909\u201315. https:\/\/doi.org\/10.1023\/a:1018890422825.","journal-title":"Pharm Res."},{"key":"3381_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103521","volume":"28","author":"P Tapfumaneyi","year":"2023","unstructured":"Tapfumaneyi P, Imran M, Alavi SE, Mohammed Y. Science of, and insights into, thermodynamic principles for dermal formulations. Drug Discov Today. 2023;28:103521. https:\/\/doi.org\/10.1016\/j.drudis.2023.103521.","journal-title":"Drug Discov Today."},{"key":"3381_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118920","volume":"575","author":"A Haq","year":"2020","unstructured":"Haq A, Chandler M, Michniak-Kohn B. Solubility-physicochemical-thermodynamic theory of penetration enhancer mechanism of action. Int J Pharm. 2020;575:118920. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118920.","journal-title":"Int J Pharm."},{"key":"3381_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijpharm.2011.01.025","volume":"407","author":"P Santos","year":"2011","unstructured":"Santos P, Watkinson AC, Hadgraft J, Lane ME. Enhanced permeation of fentanyl from supersaturated solutions in a model membrane. Int J Pharm. 2011;407:72\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.01.025.","journal-title":"Int J Pharm."},{"key":"3381_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpharm.2011.06.024","volume":"416","author":"P Santos","year":"2011","unstructured":"Santos P, Watkinson AC, Hadgraft J, Lane ME. Formulation issues associated with transdermal fentanyl delivery. Int J Pharm. 2011;416:155\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.06.024.","journal-title":"Int J Pharm."},{"key":"3381_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118582","volume":"569","author":"Y Hirakawa","year":"2019","unstructured":"Hirakawa Y, Ueda H, Miyano T, Kamiya N, Goto M. New insight into transdermal drug delivery with supersaturated formulation based on co-amorphous system. Int J Pharm. 2019;569:118582. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118582.","journal-title":"Int J Pharm."},{"key":"3381_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105667","volume":"158","author":"Y Hirakawa","year":"2021","unstructured":"Hirakawa Y, Ueda H, Takata Y, Minamihata K, Wakabayashi R, Kamiya N, et al. Co-amorphous formation of piroxicam-citric acid to generate supersaturation and improve skin permeation. Eur J Pharm Sci. 2021;158:105667. https:\/\/doi.org\/10.1016\/j.ejps.2020.105667.","journal-title":"Eur J Pharm Sci."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03381-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03381-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03381-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:50:43Z","timestamp":1780390243000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03381-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3381"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03381-y","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"It was used for sentence correction.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"A.I. Disclaimer"}}],"article-number":"146"}}